REPORT ID 4772

United States Marburgvirus Infection Market Report 2017

Publish Date
19-Dec-17
Pages
111
Format
Electronic (PDF)

In this report, the United States Marburgvirus Infection market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Marburgvirus Infection in these regions, from 2012 to 2022 (forecast).

United States Marburgvirus Infection market competition by top manufacturers/players, with Marburgvirus Infection sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Arno Therapeutics Inc
    BioCryst Pharmaceuticals Inc
    Eisai Co Ltd
    Emergent BioSolutions Inc
    Fab'entech SA
    Integrated BioTherapeutics Inc
    Johnson & Johnson
    NanoViricides Inc
    Profectus BioSciences Inc
    Rodos BioTarget GmbH
    Sarepta Therapeutics Inc
    Theravectys SA

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Eritoran Tetrasodium
    AR-12
    ARD-5
    AVI-7288
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Clinic
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Marburgvirus Infection Market Report 2017
1 Marburgvirus Infection Overview
    1.1 Product Overview and Scope of Marburgvirus Infection
    1.2 Classification of Marburgvirus Infection by Product Category
        1.2.1 United States Marburgvirus Infection Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Marburgvirus Infection Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Eritoran Tetrasodium
        1.2.4 AR-12
        1.2.5 ARD-5
        1.2.6 AVI-7288
        1.2.7 Others
    1.3 United States Marburgvirus Infection Market by Application/End Users
        1.3.1 United States Marburgvirus Infection Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 United States Marburgvirus Infection Market by Region
        1.4.1 United States Marburgvirus Infection Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Marburgvirus Infection Status and Prospect (2012-2022)
        1.4.3 Southwest Marburgvirus Infection Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Marburgvirus Infection Status and Prospect (2012-2022)
        1.4.5 New England Marburgvirus Infection Status and Prospect (2012-2022)
        1.4.6 The South Marburgvirus Infection Status and Prospect (2012-2022)
        1.4.7 The Midwest Marburgvirus Infection Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Marburgvirus Infection (2012-2022)
        1.5.1 United States Marburgvirus Infection Sales and Growth Rate (2012-2022)
        1.5.2 United States Marburgvirus Infection Revenue and Growth Rate (2012-2022)

2 United States Marburgvirus Infection Market Competition by Players/Suppliers
    2.1 United States Marburgvirus Infection Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Marburgvirus Infection Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Marburgvirus Infection Average Price by Players/Suppliers (2012-2017)
    2.4 United States Marburgvirus Infection Market Competitive Situation and Trends
        2.4.1 United States Marburgvirus Infection Market Concentration Rate
        2.4.2 United States Marburgvirus Infection Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Marburgvirus Infection Manufacturing Base Distribution, Sales Area, Product Type

3 United States Marburgvirus Infection Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Marburgvirus Infection Sales and Market Share by Region (2012-2017)
    3.2 United States Marburgvirus Infection Revenue and Market Share by Region (2012-2017)
    3.3 United States Marburgvirus Infection Price by Region (2012-2017)

4 United States Marburgvirus Infection Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Marburgvirus Infection Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Marburgvirus Infection Revenue and Market Share by Type (2012-2017)
    4.3 United States Marburgvirus Infection Price by Type (2012-2017)
    4.4 United States Marburgvirus Infection Sales Growth Rate by Type (2012-2017)

5 United States Marburgvirus Infection Sales (Volume) by Application (2012-2017)
    5.1 United States Marburgvirus Infection Sales and Market Share by Application (2012-2017)
    5.2 United States Marburgvirus Infection Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Marburgvirus Infection Players/Suppliers Profiles and Sales Data
    6.1 Arno Therapeutics Inc
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Marburgvirus Infection Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Arno Therapeutics Inc Marburgvirus Infection Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 BioCryst Pharmaceuticals Inc
        6.2.2 Marburgvirus Infection Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 BioCryst Pharmaceuticals Inc Marburgvirus Infection Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Eisai Co Ltd
        6.3.2 Marburgvirus Infection Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Eisai Co Ltd Marburgvirus Infection Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Emergent BioSolutions Inc
        6.4.2 Marburgvirus Infection Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Emergent BioSolutions Inc Marburgvirus Infection Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Fab'entech SA
        6.5.2 Marburgvirus Infection Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Fab'entech SA Marburgvirus Infection Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Integrated BioTherapeutics Inc
        6.6.2 Marburgvirus Infection Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Integrated BioTherapeutics Inc Marburgvirus Infection Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Johnson & Johnson
        6.7.2 Marburgvirus Infection Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Johnson & Johnson Marburgvirus Infection Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 NanoViricides Inc
        6.8.2 Marburgvirus Infection Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 NanoViricides Inc Marburgvirus Infection Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Profectus BioSciences Inc
        6.9.2 Marburgvirus Infection Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Profectus BioSciences Inc Marburgvirus Infection Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Rodos BioTarget GmbH
        6.10.2 Marburgvirus Infection Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Rodos BioTarget GmbH Marburgvirus Infection Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Sarepta Therapeutics Inc
    6.12 Theravectys SA

7 Marburgvirus Infection Manufacturing Cost Analysis
    7.1 Marburgvirus Infection Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Marburgvirus Infection

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Marburgvirus Infection Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Marburgvirus Infection Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Marburgvirus Infection Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Marburgvirus Infection Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Marburgvirus Infection Sales Volume Forecast by Type (2017-2022)
    11.3 United States Marburgvirus Infection Sales Volume Forecast by Application (2017-2022)
    11.4 United States Marburgvirus Infection Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer